The guidelines include 46 evidence- and consensus-based recommendations about the use of methotrexate for inflammatory skin disease in pediatric patients developed by a committee of 23 experts.
Patients with head and neck cancer and obesity saw better treatment response and survival after chemoradiation, compared with patients with the same type of cancer but a normal weight.
Data on the course and prognosis of warts in pediatric patients being treated for cancer compared with patients who have completed treatment have been limited.